|
Session 3: Vision for Products with Impact and Sustainable Access
|
|
9:00 – 9:30 a.m.
|
Round Table: PD-1 checkpoint therapies from China: local experience and plans for emerging markets
Moderator:
Wenru Song, MD, PhD – Kira Pharma
Panelists:
Shirley Zhao – CStone Pharmaceuticals
Yong Ben, MD, MBA – BeiGene
Sheng Yao, MD – Shanghai Junshi Biosciences Co.
|
|
9:30 – 9:50 a.m.
|
Barriers and approaches to cancer immunotherapy in LMICs
Ute Dugan, MD, PhD – Parker Institute for Cancer Immunotherapy
Phangisile Mtshali – Bristol-Myers Squibb Foundation
|
|
9:50 – 10:10 a.m.
|
Bintrafusp Alfa, a bifunctional fusion protein targeting TGF-β and PD-L1, in HPV–associated malignancies
Claudia-Nanette Gann, MD – EMD Serono
|
|
10:10 – 10:30 a.m.
|
Roche perspective on global access to cancer therapies, including I-O
Frank Loeffler – Roche
Philip Anderson, MD – Roche
|
|
10:30 – 10:50 a.m.
|
Panel discussion
Moderator:
Phangisile Mtshali – Bristol-Myers Squibb Foundation
Panelists:
Ute Dugan, MD, PhD – Parker Institute for Cancer Immunotherapy
Claudia-Nanette Gann, MD – EMD Serono
Frank Loeffler – Roche
Philip Anderson, MD – Roche
|
|
10:50 – 11:00 a.m.
|
Break
|
|
Session 4: Scientific Questions That Need to be Answered in LMIC’s
|
|
11:00 – 11:20 a.m.
|
Presentation and survival from breast cancer in SSA
Nixon Niyonzima, MD – Uganda Cancer Institute
|
|
11:20 – 11:40 a.m.
|
Evaluation of immune checkpoint inhibitors in medically vulnerable populations: challenges and opportunities for translational research
Elad Sharon, MD, MPH – National Cancer Institute
|
| 11:40 – 12:00 p.m.
|
Cervical cancer and checkpoint blockade
Alfonso Dueñas – Instituto Nacional de Cancerología
|
12:00 - 12:20
p.m. |
Panel discussion
Moderator:
Verna Vanderpuye, MD – Bu Teaching Hospital
Panelists:
Ramya Ramaswami, MBBS, MPH – National Cancer Institute
Elad Sharon, MD, MPH – National Cancer Institute
Nixon Niyonzima, MD – Uganda Cancer Institute
Alfonso Dueñas – Instituto Nacional de Cancerología
Adedayo Joseph, MD – NSIA-LUTH Cancer Center
Thomas Uldrick, MD, MS – Fred Hutchinson Cancer Research Center
|
|
Session 5: Wrap-up: Next Steps and Line of Sight to Recommendations
|
12:20 - 12:40
p.m. |
Accelerating access to cancer immunotherapies: Learning from the global health experience of CHAI, American Cancer Society, and Allied Against Cancer
Emily Kobayashi – Clinton Health Access Initiative
|
| 12:40 - 1:00 p.m |
Round Table: Networking to increase cooperation between regions: Clinical trials, sharing of epidemiologic data, and other areas for collaboration
Moderator:
Nora Sobrevilla-Moreno, MD – Instituto Nacional de Cancerología
Panelists:
Marisa Nimrod, MD – Caribbean Association of Hematology and Oncology
Hanna Simonds, MBChB, MRCP, FRCR – Stellenbosch University
Oscar Arrieta, MD, MS – Instituto Nacional de Cancerología
Addu Bounedja – Saad Dahlab University
|
| 1:00 - 1:25 p.m. |
Panel discussion
Moderator:
Fredrick Chite Asirwa, MD – International Cancer Institute Eldoret
Panelists:
Satish Gopal, MD, MPH – National Cancer Institute
David Kaufman, MD, PhD – Third Rock Ventures
Samir Khleif, MD – Georgetown University
Verna Vanderpuye, MD – Bu Teaching Hospital
Nora Sobrevilla-Moreno, MD – Instituto Nacional de Cancerología
Tolulope Adewole, MBBS – NSIA-LUTH Cancer Center
Zainab Mohamed, MBChB, MMed – University of Cape Town
Ute Dugan, MD, PhD – Parker Institute for Cancer Immunotherapy
|
| 1:25 - 1:30 p.m. |
Conclusion and thank you
David Kaufman, MD, PhD – Third Rock Ventures
|